-
Dapagliflozin for treating chronic heart failure with reduced ejection fractionNational Institue for Health and Care Excellence -
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart FailureDB Mark, PA Cowper, KJ Anstrom et al.
-
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert PanelJE Wilcox, JC Fang, KB Margulies et al.
-
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection FractionA Samman-Tahhan, JS Hedley, AA. McCue et al.
-
Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art ReviewM.G.D Buono, R Arena, BA Borlaug et al.
-
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart FailureJA Chirinos, L Zhao, Y Jia et al.
-
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 StudyKosiborod M, Lam CSP, CVD-REAL Investigators and Study Group.
-
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionShen L, Jhund PS, McMurray JJV et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
